» Articles » PMID: 18349384

Genetic Variant in the Glucose Transporter Type 2 is Associated with Higher Intakes of Sugars in Two Distinct Populations

Overview
Date 2008 Mar 20
PMID 18349384
Citations 43
Authors
Affiliations
Soon will be listed here.
Abstract

Glucose sensing in the brain has been proposed to be involved in regulating food intake, but the mechanism is not known. Glucose transporter type 2 (GLUT2)-null mice fail to control their food intake in response to glucose, suggesting a potential role for this transporter as a glucose sensor in the brain. Here we show that individuals with a genetic variation in GLUT2 (Thr110Ile) have a higher daily intake of sugars in two distinct populations. In the first population, compared with individuals with the Thr/Thr genotype, carriers of the Ile allele had a significantly higher intake of sugars as assessed from 3-day food records administered on two separate visits (visit 1: 112 +/- 9 vs. 86 +/- 4 g/day, P = 0.01; visit 2: 111 +/- 8 vs. 82 +/- 4 g/day, P = 0.003), demonstrating within-population reproducibility. In a second population, carriers of the Ile allele also reported consuming a significantly greater intake of sugars (131 +/- 5 vs. 115 +/- 3 g/day, P = 0.007) over a 1-mo period as measured from a food frequency questionnaire. GLUT2 genotypes were not associated with fat, protein, or alcohol intake in either population. These observations were consistent across older and younger adults as well as among subjects with early Type 2 diabetes and healthy individuals. Taken together, our findings show that a genetic variation in GLUT2 is associated with habitual consumption of sugars, suggesting an underlying glucose-sensing mechanism that regulates food intake.

Citing Articles

Nutritional Genomics and Cancer Prevention.

Aslam S, Iqbal R, Saeed R, Akram N, Ijaz F, Liaqat I Cancer Treat Res. 2024; 191:217-244.

PMID: 39133410 DOI: 10.1007/978-3-031-55622-7_9.


The role of diet in cancer: the potential of shaping public policy and clinical outcomes in the UK.

Britten O, Tosi S Genes Nutr. 2024; 19(1):15.

PMID: 39097687 PMC: 11298086. DOI: 10.1186/s12263-024-00750-9.


Genetic variant panel allows predicting both obesity risk, and efficacy of procedures and diet in weight loss.

Mera-Charria A, Nieto-Lopez F, Frances M, Arbex P, Vila-Vecilla L, Russo V Front Nutr. 2023; 10:1274662.

PMID: 38035352 PMC: 10687570. DOI: 10.3389/fnut.2023.1274662.


Specific Genotypes Associated with Differences in Fasting Insulin Levels and Body Mass Index in Healthy Young Males: Implications for Gene-Nutrient Interactions-an Exploratory Study.

Brown J, Pham T, Burden H, Braakhuis A Curr Dev Nutr. 2023; 7(11):102018.

PMID: 38026570 PMC: 10663744. DOI: 10.1016/j.cdnut.2023.102018.


A phenome-wide comparative analysis of genetic discordance between obesity and type 2 diabetes.

Coral D, Fernandez-Tajes J, Tsereteli N, Pomares-Millan H, Fitipaldi H, Mutie P Nat Metab. 2023; 5(2):237-247.

PMID: 36703017 PMC: 9970876. DOI: 10.1038/s42255-022-00731-5.